The Vital Role of 131I-MIBG in Localization of Paraganglioma at Unusual Sites
Abstract: Paragangliomas (PGLs) are extra-adrenal neuroendocrine tumors. PGL of the urinary bladder are very rare and commonly present with features of hypertensive crisis, headache, syncope, and other symptoms of sympathetic excess. A few of these tumors are silent at the presentation. Here, we report a case of a urinary bladder PGL, presenting with lower abdominal pain.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
The Vital Role of 131I-MIBG in Localization of Paraganglioma at Unusual Sites ; volume:21 ; number:03 ; year:2022 ; pages:251-254
World Journal of Nuclear Medicine ; 21, Heft 03 (2022), 251-254
- Contributor
-
Singhal, Tejasvini
Singh, Parneet
Veerwal, Hardik
Narayan, Manishi L.
- DOI
-
10.1055/s-0042-1751054
- URN
-
urn:nbn:de:101:1-2022111011431003085297
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Singhal, Tejasvini
- Singh, Parneet
- Veerwal, Hardik
- Narayan, Manishi L.
Other Objects (12)
Unusual presentation of bladder paraganglioma: Comparison of 131I MIBG SPECT/CT and 68Ga DOTANOC PET/CT
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG
Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
![Der Einsatz von [131I]Metaiodobenzylguanidin ([131I]mIBG) zur Diagnostik und Therapie des Neuroblastoms : klinische, klinisch pharmakologische, dosimetrische und experimentelle Untersuchungen](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Der Einsatz von [131I]Metaiodobenzylguanidin ([131I]mIBG) zur Diagnostik und Therapie des Neuroblastoms : klinische, klinisch pharmakologische, dosimetrische und experimentelle Untersuchungen
Der Effekt der 131I-mIBG Therapie auf den SIOPEN und modifizierten Curie Score
Imaging of pheochromocytoma and paraganglioma: moving beyond “lumpology” with SSTR, FDG and MIBG molecular imaging
Metastatic Pheochromocytoma Diagnosed with 131I-MIBG SPECT/CT Imaging in a Patient with Pathogenic VHL Mutation
Metastatic Extra-Adrenal Pheochromocytoma with Single Kidney and Renal Compromise: A Case Report of Excellent Response, Tolerability, and Outcome to a Modified Regimen of 131I-mIBG, and Decision-Making between 131I-mIBG Therapy and PRRT
Aufnahme von [131I]mIBG und [3H]Noradrenalin in Neuroblastomzellen : Einfluss der Vorbehandlung der Zellen mit Zytostatika
A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma
Unusual presentation of bladder paraganglioma: Comparison of 131I MIBG SPECT/CT and 68Ga DOTANOC PET/CT
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG
Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
Der Einsatz von [131I]Metaiodobenzylguanidin ([131I]mIBG) zur Diagnostik und Therapie des Neuroblastoms : klinische, klinisch pharmakologische, dosimetrische und experimentelle Untersuchungen
Der Effekt der 131I-mIBG Therapie auf den SIOPEN und modifizierten Curie Score
Imaging of pheochromocytoma and paraganglioma: moving beyond “lumpology” with SSTR, FDG and MIBG molecular imaging
Metastatic Pheochromocytoma Diagnosed with 131I-MIBG SPECT/CT Imaging in a Patient with Pathogenic VHL Mutation
Metastatic Extra-Adrenal Pheochromocytoma with Single Kidney and Renal Compromise: A Case Report of Excellent Response, Tolerability, and Outcome to a Modified Regimen of 131I-mIBG, and Decision-Making between 131I-mIBG Therapy and PRRT
Aufnahme von [131I]mIBG und [3H]Noradrenalin in Neuroblastomzellen : Einfluss der Vorbehandlung der Zellen mit Zytostatika
A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma
Unusual presentation of bladder paraganglioma: Comparison of 131I MIBG SPECT/CT and 68Ga DOTANOC PET/CT
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG
Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
Der Einsatz von [131I]Metaiodobenzylguanidin ([131I]mIBG) zur Diagnostik und Therapie des Neuroblastoms : klinische, klinisch pharmakologische, dosimetrische und experimentelle Untersuchungen
Der Effekt der 131I-mIBG Therapie auf den SIOPEN und modifizierten Curie Score
Imaging of pheochromocytoma and paraganglioma: moving beyond “lumpology” with SSTR, FDG and MIBG molecular imaging
Metastatic Pheochromocytoma Diagnosed with 131I-MIBG SPECT/CT Imaging in a Patient with Pathogenic VHL Mutation
Metastatic Extra-Adrenal Pheochromocytoma with Single Kidney and Renal Compromise: A Case Report of Excellent Response, Tolerability, and Outcome to a Modified Regimen of 131I-mIBG, and Decision-Making between 131I-mIBG Therapy and PRRT
Aufnahme von [131I]mIBG und [3H]Noradrenalin in Neuroblastomzellen : Einfluss der Vorbehandlung der Zellen mit Zytostatika